13 Aug 2010
Checked the Interactions between the 2 meds, and it has been recommended to be monitored:
Applies to: Lipitor (atorvastatin), Valturna (aliskiren/valsartan)
MONITOR: Coadministration with atorvastatin may increase the plasma concentrations of aliskiren. The exact mechanism of interaction is unknown but may involve competitive inhibition of the CYP450 3A4 metabolism of aliskiren. According to the product labeling, peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) of aliskiren were increased approximately 50% by atorvastatin following multiple dosing. Aliskiren had no significant effect on the pharmacokinetics of atorvastatin.
MANAGEMENT: Caution is advised during coadministration of aliskiren with atorvastatin. Antihypertensive response should be monitored more closely following initiation, discontinuation, or change of dosage of atorvastatin in patients who are stabilized on their aliskiren regimen. Patients should be advised to notify their physician if they experience excessive adverse effects of aliskiren such as dizziness, lightheadedness, diarrhea, abdominal pain, and gastroesophageal reflux.
Please for technical details talk to the doc who prescribed the med, hope the info helps?
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
My mom has headaches & dizziness from valturna as precribed by her doctor- should she stop using it?
.She is almost 80 and has had a couple of mini strokes and her bp is always high and she lost her husband a week ago...
1 answer • 15 Feb 2011
high since starting,the rate being between 85-109 without any exertion on my part.In the AM it's about 85,before taking my daily pill,however it ...
0 answers • 10 May 2011
I was told by my pharmacist that Valturna is no longer manufacturer and there is a "warning" is this true?
1 answer • 20 Sep 2012
I've tried exercise and pain medication, to no avail, and I'm wondering if it could be the lipitor. A pharmacist told me "highly ...
2 answers • 18 Mar 2013